drugset / Trial / NCT00086983
Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This phase I trial is studying the side effects and best dose of rebeccamycin analog and oxaliplatin in treating patients with refractory solid tumors. Drugs used in chemotherapy, such as rebeccamycin analog and oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells
Timeline
- Start
- 2004-05
- Primary completion
- 2006-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | Intravenous |
| Subject | becatecarin | Other / unclassified | — | Intravenous |
Indications
No indication recorded.